We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
DNA

Price
8.12
Stock movement up
+0.82 (11.23%)
Company name
Ginkgo Bioworks Holdings
Exchange
(NYSE
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
367.02M
Ent value
433.74M
Price/Sales
1.68
Price/Book
0.46
Div yield
-
Div growth
-
Growth years
-
FCF payout
-0.15%
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-81.88%
3 year return
-61.40%
5 year return
-
10 year return
-
Last updated: 2025-04-11

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

DNA does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales1.68
Price to Book0.46
EV to Sales1.99

FINANCIALS

Per share

Loading...
Per share data
Current share count45.20M
EPS (TTM)-12.46
FCF per share (TTM)-7.23

Income statement

Loading...
Income statement data
Revenue (TTM)217.95M
Gross profit (TTM)138.89M
Operating income (TTM)-591.34M
Net income (TTM)-651.19M
EPS (TTM)-12.46
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)63.73%
Operating margin (TTM)-271.32%
Profit margin (TTM)-298.78%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash616.21M
Net receivables23.41M
Total current assets662.48M
Goodwill0.00
Intangible assets79.57M
Property, plant and equipment0.00
Total assets1.48B
Accounts payable15.70M
Short/Current long term debt445.59M
Total current liabilities114.43M
Total liabilities682.94M
Shareholder's equity797.94M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-325.70M
Capital expenditures (TTM)52.28M
Free cash flow (TTM)-377.98M
Dividends paid (TTM)554.00K

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-81.61%
Return on Assets-43.97%
Return on Invested Capital-81.61%
Cash Return on Invested Capital-47.37%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open7.50
Daily high8.40
Daily low7.25
Daily Volume3.13M
All-time high596.80
1y analyst estimate8.20
Beta1.10
EPS (TTM)-12.46
Dividend per share-
Ex-div date-
Next earnings date13 Jun 2025

Downside potential

Loading...
Downside potential data
DNAS&P500
Current price drop from All-time high-98.64%-12.89%
Highest price drop-99.10%-56.47%
Date of highest drop9 Sep 20249 Mar 2009
Avg drop from high-74.30%-11.07%
Avg time to new high84 days12 days
Max time to new high860 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
DNA (Ginkgo Bioworks Holdings) company logo
Marketcap
367.02M
Marketcap category
Small-cap
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Employees
1218
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
No events found

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...